ATAnita Blanka Tryc

Anita Blanka Tryc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anita Blanka Tryc has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chronic Neurotoxicity of Calcineurin Inhibitors in Patients After Liver Transplantation

    by Henning Pflugrad, Anita B. Tryc, Anna-Kristina Schrader, Xiaoqi Ding, Heinrich Lanfermann, Elmar Jäckel, Harald Schrem, Jan Beneke, Hannelore Barg-Hock, Jürgen Klempnauer, et al.

  • Open Access

    Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection

    by Hans Worthmann, Anita B Tryc, Meike Dirks, Ramona Schuppner, Korbinian Brand, Frank Klawonn, Ralf Lichtinghagen, Karin Weissenborn

    Ischemic stroke patients are prone to infection by stroke-induced immunodepression. We hypothesized that levels of lipopolysaccharide binding protein (LBP), interleukin-10 (IL-10), IL-6 and C-reactive protein (CRP) are early predictors for the development of stroke-associated infection. Fifty-six patients with ischemic stroke (n = 51) and transient ischemic attack (TIA) (n = 5) who presented within 6 hours after symptom onset and who were free of detectable infection on admission were included in the study. Of these, 20 developed early infections during the first week. Blood samples were taken at 6, 12, and 24 hours and at 3 and 7 days after stroke onset. Levels of LBP, Il-10, IL-6 and CRP, as well as S100B, were measured as markers of inflammation and brain damage by commercially available immunometric tests. In the univariate analysis, levels of LBP, IL-10, IL-6 and CRP significantly differed between patients who developed an infection and those who did not. In the binary logistic regression analysis, which was adjusted for National Institutes of Health Stroke Scale (NIHSS) on admission, stroke subtype and S100B peak levels, as indicator of the extent of brain damage, IL-10 at 6 hours, CRP at 6 hours and NIHSS on admission were identified as independent predictors of infection (IL-10: P = 0.009; CRP: P = 0.018; NIHSS: P = 0.041). The area under the curve (AUC) of the receiver operating characteristic (ROC) curves in relation to the dichotomized status of the infection (infection versus no infection) was 0.74 (95% confidence interval: 0.59 to 0.88) for CRP at 6 hours, 0.76 (0.61 to 0.9) for IL-10 at 6 hours, 0.83 (0.71 to 0.94) for NIHSS on admission and 0.94 (0.88 to 1) for the combination of CRP, IL-10 and NIHSS. In a subanalysis, 16 patients with early infections were matched with 16 patients without infection according to S100B peak levels. Here, the temporal pattern of LBP, IL-10, IL-6 and CRP significantly differed between the patient groups. Our data show that blood levels of inflammation markers may be used as early predictors of stroke-associated infection. We propose prospective studies to investigate if the calculated cut-offs of CRP, IL-10 and NIHSS might help to identify patients who should receive early preventive antibiotic treatment.


  • Open Access

    Central nervous system complications after liver transplantation: Common but mostly transient phenomena

    by Martina Bernhardt, Henning Pflugrad, Annemarie Goldbecker, Hannelore Barg‐Hock, Wolfgang Knitsch, Jürgen Klempnauer, Christian P. Strassburg, Hartmut Hecker, Karin Weissenborn, Anita Blanka Tryc

    Although central nervous system complications (CNSCs) are common after orthotopic liver transplantation (OLT), standardized prospective studies are still lacking. This prospective study was aimed at determining the incidence of CNSCs, describing their clinical presentations, and establishing predicting factors. One hundred thirty‐six adult patients who underwent OLT at Hannover Medical School between December 2008 and June 2011 were included. Weekly examinations were performed by a neurologist during the hospital stay after OLT. Patient data, donor data, and operative and postoperative variables were collected. Patients with cerebral dysfunction after OLT underwent a diagnostic work‐up, which included brain imaging and, if necessary, cerebrospinal fluid analysis. Patients with central nervous system (CNS) symptoms but negative imaging and cerebrospinal fluid results and patients with pontine myelinolysis or posterior reversible encephalopathy syndrome were placed in a metabolic‐toxic CNSC group, and patients with strokes, intracranial hemorrhaging, or CNS infections were placed in a nonmetabolic CNSC group. Multiple regression analysis was used to identify independent risk factors for the development of metabolic‐toxic CNSCs. After excluding two patients that died after OLT without regaining consciousness, forty‐four (32.8%) patients developed CNSCs: 37 of these patients (27.6%) had metabolic‐toxic CNSCs, and 7 (5.2%) had nonmetabolic CNSCs. Acute‐on‐chronic liver failure, the number of subsequent surgeries, and primary sclerosing cholangitis were identified as independent predictors for the development of metabolic‐toxic CNSCs. Metabolic‐toxic CNSCs were associated with prolonged hospital stays, and nonmetabolic CNSCs were associated with higher mortality. In conclusion, CNSCs are common and relevant complications after OLT. Patients after OLT, especially with risk factors, should undergo a regular standardized neurological examination that would allow early detection of these complications. Liver Transpl 21:224‐232, 2015. © 2014 AASLD.


  • Open Access

    The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome

    by Gerrit M Grosse, Anita B Tryc, Meike Dirks, Ramona Schuppner, Henning Pflugrad, Ralf Lichtinghagen, Karin Weissenborn, Hans Worthmann

    The chemokine fractalkine (CX3CL1, FKN) is involved in neural-microglial interactions and is regarded as neuroprotective according to several in vivo studies of inflammatory and degenerative states of the brain. Recently, an association with outcome in human ischemic stroke has been proposed. In this study, we aimed to investigate the temporal pattern of FKN levels in acute ischemic stroke in relation to stroke severity and outcome.


  • Open Access

    New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation

    by Anita Blanka Tryc, Henning Pflugrad, Annemarie Goldbecker, Hannelore Barg-Hock, Christian P. Strassburg, Hartmut Hecker, Karin Weissenborn

    Patients after orthotopic liver transplantation (OLT) may show cognitive dysfunction. To date, it has not been clear whether this dysfunction is due to residual hepatic encephalopathy (HE) or new-onset cognitive disturbances. Just as little is known about the course and clinical significance. In this prospective, observational study, 50 patients on the waiting list for OLT were examined in an outpatient setting before OLT and 6 and 12 months after OLT with the Psychometric Hepatic Encephalopathy Score, the Inhibitory Control Test, and the critical flicker frequency for the diagnosis of HE; in addition, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used as a tool for the measurement of global cognitive function. The Short Form 36 health survey was used to assess health-related quality of life. Twelve months after OLT, cognitive dysfunction characteristic of HE had resolved, but a secondary cognitive decline became apparent and had features different from those known with HE. Approximately 70% of the patients deteriorated in at least 1 cognitive domain of RBANS. This cognitive decline was related to neither a history of HE nor a history of alcohol abuse, but it was accompanied by a decline in the quality of life. In conclusion, OLT improves HE but is frequently followed by new-onset cognitive dysfunction, which can interfere with the quality of life. Liver Transpl 20:807–814, 2014. © 2014 AASLD.


  • Open Access

    Association of dimethylarginines and mediators of inflammation after acute ischemic stroke

    by Shufen Chen, Jens Martens-Lobenhoffer, Karin Weissenborn, Jan T Kielstein, Ralf Lichtinghagen, Milani Deb-Chatterji, Na Li, Anita B Tryc, Annemarie Goldbecker, Qiang Dong, et al.

    Elevated levels of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are accompanied by endothelial dysfunction and predict adverse outcome after ischemic stroke. Via induction of oxidative stress, dimethylarginines are possibly linked to the inflammatory cascade after stroke that is known to considerably contribute to secondary progression of brain injury. We sought to investigate the association between dimethylarginines and inflammatory mediators in patients with acute ischemic stroke.


  • Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controls

    by Munir Rababah, Hans Worthmann, Milani Deb, Anita B. Tryc, Yue Tao Ma, Omnia M. El Bendary, Hartmut Hecker, Annemarie Goldbecker, Meike Heeren, Korbinian Brand, et al.


  • Open Access

    Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease

    by Anita Blanka Tryc, Güldan Alwan, Martin Bokemeyer, Annemarie Goldbecker, Hartmut Hecker, Marion Haubitz, Karin Weissenborn

    Background. The diagnosis of uraemic encephalopathy is considered if patients with end-stage renal disease present with neuropsychiatric symptoms. However, cognitive deficits may occur in patients with chronic kidney disease (CKD) long before any overt neurological symptoms can be observed. We hypothesized that cognitive dysfunction in patients with CKD both, treated and untreated by haemodialysis, may correspond to metabolic changes in distinct brain regions. Methods. We performed magnetic resonance spectroscopy (MRS) ( 1 H-MRS) of the brain in 23 non-dialysed patients with CKD (Stages 4–5) and in 15 haemodialysed patients. Healthy controls ( n = 63) adjusted for age and education were recruited from the social environment of the patients' population. Attention, learning and memory were assessed by psychometric testing. Results. MRS alterations were predominantly found in the white matter. Concentrations of creatine-containing compounds (Cr) were decreased in dialysed and non-dialysed patients. Choline concentration (Cho) and combined N -acetylaspartate and N -acetylaspartylglutamate concentration (NAx) were reduced only in dialysed patients. Disturbance in memory and learning ability as well as attention deficits were observed in both patient groups. Of note, attention deficits were more severe in dialysed patients. MRS results correlated with attention deficits in dialysed patients. Conclusions. CKD patients without clinical signs of uraemic encephalopathy showed metabolic disturbances in distinct brain regions as well as cognitive impairments. Haemodialysis was accompanied with more severe cognitive dysfunction and metabolic alternations than CKD alone. Although the small sample size limits the interpretation of the data, a negative impact of haemodialysis on cognitive function must be considered.